In this study, we explored the multifaceted role of transmembrane and ubiquitin-like domain-containing 1 (TMUB1) in glioma, shedding light on its potential as a diagnostic biomarker, a prognostic indicator, and even a therapeutic target. Here, TMUB1 is linked to central nervous system cancer.